WCN26-7699 B-CELL–TARGETED THERAPY FOR IDIOPATHIC NEPHROTIC SYNDROME: RESULTS OF THE PHASE III, GLOBAL, MULTICENTER INSHORE TRIAL ASSESSING OBINUTUZUMAB VS MYCOPHENOLATE MOFETIL

Kidney International Reports 2026 Open access

Read full text
Authors: Julien Hogan, Larry A. Greenbaum, Kandai Nozu, Malgorzata Mizerska-Wasiak, Andreia Watanabe, Andrea Angeletti, Kenneth Lieberman, Jie Ding, Toru Uchimura, Franz Schaefer, Theodore A. Omachi, Ben Lanza
+3 more Benoît Meger, Heather Boston, Patricia B. Lehane
DOI: 10.1016/j.ekir.2026.106510
Cited by: 1

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Kidney Stones and Urolithiasis Treatments Renal and related cancers

Publication details

Journal / source
Kidney International Reports
Publisher
Elsevier BV
Volume
11
Issue
5
Pages
106510–106510
Publication date
1 May 2026
Language
EN